How many institutions held FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in Q4 2022?

30 institutional investors reported FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share for Q4 2022. Use the holders table for investor-level position and value details.

Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)

Q: What does CUSIP 34962G109 represent in this 13F holders report?

CUSIP 34962G109 is the security identifier for FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 34962G109

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 20,563,488
Total 13F shares: 3,801,902
Share change: -327,753
Total reported value: $3,800,654
Put/Call ratio: 3%
Price per share: $1.00
Number of holders: 30
Value change: -$331,796
Number of buys: 13
Number of sells: 11

Quarterly Holders Quick Answers

What is CUSIP 34962G109?
CUSIP 34962G109 identifies FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 34962G109:

Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022

Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	3.1%	647,293	$692,000	—	30 Sep 2022	13F
Newtyn Management, LLC	13F	Company	2.4%	500,000	$535,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.2%	444,129	$475,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	1%	211,646	$226,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.93%	191,053	$204,000	—	30 Sep 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.76%	156,456	$167,000	—	30 Sep 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.64%	131,094	$140,000	—	30 Sep 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.47%	97,103	$104,000	—	30 Sep 2022	13F
Old Well Partners, LLC	13F	Company	0.33%	68,600	$73,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	0.2%	41,664	$45,000	—	30 Sep 2022	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.18%	36,865	$39,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	0.13%	26,379	$28,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.1%	20,383	$22,000	—	30 Sep 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.09%	19,053	$20,000	—	30 Sep 2022	13F
Ergoteles LLC	13F	Company	0.09%	18,212	$19,000	—	30 Sep 2022	13F
Virtu Financial LLC	13F	Company	0.07%	14,139	$15,000	—	30 Sep 2022	13F
Aries Wealth Management	13F	Company	0.06%	13,000	$14,000	—	30 Sep 2022	13F
HSBC HOLDINGS PLC	13F	Company	0.06%	11,906	$13,000	—	30 Sep 2022	13F
Man Group plc	13F	Company	0.05%	10,760	$12,000	—	30 Sep 2022	13F
Cutler Group LLC / CA	13F	Company	0.02%	4,387	$4,000	—	30 Sep 2022	13F
FEDERATED HERMES, INC.	13F	Company	0.02%	3,270	$3,000	—	30 Sep 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	0.01%	1,080	$2,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	0%	1,006	$1,000	—	30 Sep 2022	13F
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA	13F	Company	0%	193	$1,000	—	30 Sep 2022	13F
TD Waterhouse Canada Inc.	13F	Company	0%	100	$110	—	30 Sep 2022	13F
Patricia S. Walker	3/4/5	Director	— class O/S missing	25,000	—	—	01 Jun 2022	3/4/5

Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q4 2022

As of 31 Dec 2022, Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,801,902 shares. The largest 10 holders included BML Capital Management, LLC, VANGUARD GROUP INC, Newtyn Management, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, Old Well Partners, LLC, MILLENNIUM MANAGEMENT LLC, and TWO SIGMA INVESTMENTS, LP. This page lists 30 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.